Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world clinical use and safety of Salvianolate injection
ChiCTR-OCS-13003907Phase 4Completed
- Sponsor
- Huzhou Central Hospital
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of salvianolate, sponsored by Huzhou Central Hospital. Primary endpoint: Adverse drug reactions. Started Jul 2014; status: completed.
02
Drugs
salvianolate
Beyond the preview
Go deeper on ChiCTR-OCS-13003907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCS-13003907.